Prof. Dr. Semra MUNGAN

Yayın Ağı

Makaleler 10

1. Evaluation of AI Chatbot Responses to a Standardized Patient Query on Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: Cross-Sectional Content Analysis

Sönmez M. T., YETKİN M. F., Mehdiyev D. A., Çelik N. D., ERCAN M. B., Öztürk P., et al.

JMIR Medical Informatics , cilt.14, 2026 (SCI-Expanded, Scopus)

2. Dynamics of neutrophil-to-lymphocyte ratio and disability status during an acute relapse and corticosteroid therapy in relapsing-remitting multiple sclerosis

Akçin C., MUNGAN S., Aydin B., VURAL G., Demirdöäÿen B. C.

Turkish Journal of Biochemistry , 2026 (SCI-Expanded, Scopus, TRDizin)

3. Decoding the Potential Impact of Plasma hsa-miR-24-3p and hsa-miR-181 d-3p Expression, Plasma IFN-γ Levels, and IFNG rs2069727 T/C Genetic Variant on Multiple Sclerosis Risk and Glatiramer Acetate Treatment

Kalmaz M., MUNGAN S., Demirdöğen B. C.

Molecular Neurobiology , cilt.62, sa.10, ss.12865-12882, 2025 (SCI-Expanded, Scopus)

4. Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad Study

Sönmez M. T., YETKİN M. F., Mehdiyev D. A., KÖSEOĞLU M., MUNGAN S., Kale N., et al.

Multiple Sclerosis and Related Disorders , cilt.101, 2025 (SCI-Expanded, Scopus)

5. CLU polymorphisms and plasma clusterin levels in patients with multiple sclerosis: association with disability scores, progression rate and fingolimod therapy

Kılıç O. O., MUNGAN S., DEMİRKAYA Ş., Can Demirdöğen B.

Neurological Research , cilt.47, sa.8, ss.677-691, 2025 (SCI-Expanded, Scopus)

6. Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study

Seferoğlu M., Tunç A., Sıvacı A. Ö., TEKGÖL UZUNER G., MUNGAN S., İnanç Y., et al.

Multiple Sclerosis and Related Disorders , cilt.92, 2024 (SCI-Expanded, Scopus)

7. Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

Terzi M., Helvacı E. M., Şen S., BOZ C., Çilingir V., Akçali A., et al.

Noropsikiyatri Arsivi , cilt.60, sa.1, ss.23-27, 2023 (SCI-Expanded, Scopus, TRDizin)

8. Association between Expanded Disability Status Scale score and dietary antioxidant capacity in patients with multiple sclerosis

MUNGAN S., Guzel I., Demirdogen B.

Brazilian Journal of Medical and Biological Research , cilt.56, 2023 (SCI-Expanded, Scopus)

9. More continuous flow, better learning? The effect of aortic valve opening in patients with left ventricular assist device

Karahan M., KOCABEYOĞLU S. S., KERVAN Ü., Sert D. E., Erdogan Bakar E., Aygun E., et al.

International Journal of Artificial Organs , cilt.44, sa.5, ss.325-331, 2021 (SCI-Expanded, Scopus)

10. Effects of continuous-flow left ventricular assist devices on cerebral hemodynamics

Karahan M., KOCABEYOĞLU S. S., KERVAN Ü., Sert D. E., Aygun E., TOLA M., et al.

Artificial Organs , cilt.44, sa.5, ss.457-464, 2020 (SCI-Expanded, Scopus)

Metrikler

Prof. Dr. Semra MUNGAN

Yayınlar & Eserler

1. Evaluation of AI Chatbot Responses to a Standardized Patient Query on Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: Cross-Sectional Content Analysis

2. Dynamics of neutrophil-to-lymphocyte ratio and disability status during an acute relapse and corticosteroid therapy in relapsing-remitting multiple sclerosis

3. Decoding the Potential Impact of Plasma hsa-miR-24-3p and hsa-miR-181 d-3p Expression, Plasma IFN-γ Levels, and IFNG rs2069727 T/C Genetic Variant on Multiple Sclerosis Risk and Glatiramer Acetate Treatment

4. Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad Study

5. CLU polymorphisms and plasma clusterin levels in patients with multiple sclerosis: association with disability scores, progression rate and fingolimod therapy

6. Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study

7. Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment

8. Association between Expanded Disability Status Scale score and dietary antioxidant capacity in patients with multiple sclerosis

9. More continuous flow, better learning? The effect of aortic valve opening in patients with left ventricular assist device

10. Effects of continuous-flow left ventricular assist devices on cerebral hemodynamics

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim